Skip to main content

Advertisement

Table 5 Effect of clustering of components of Metabolic Syndrome on microangiopathies

From: Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14)

   Prevalence of Microangiopathies
Components of MS   Diabetic Retinopathy Diabetic Nephropathy Diabetic Neuropathy
  N n % Trend p n % Trend p n % Trend p
Overall (n = 1043)           
   + Any one 309 39 12.6 0.193 43 13.9 0.013 65 21.2 0.929
   +Any two 448 90 20.1   83 18.5   75 16.8  
   + Any three 286 47 16.4   62 21.7   61 21.6  
Men (n = 490)           
   + Any one 171 30 17.5 0.779 27 15.8 0.945 46 26.9 0.077
   +Any two 193 44 22.8   34 17.6   33 17.1  
   + Any three 126 23 18.3   20 15.9   24 19.2  
Women (n = 553)           
   + Any one 138 9 6.5 0.049 16 11.6 0.001 19 14.0 0.030
   +Any two 255 46 18.0   49 19.2   42 16.6  
   + Any three 160 24 15.0   42 26.3   37 23.6  
  1. MS, Metabolic Syndrome; MS absent, Diabetes only or Diabetes + Obesity; + Any one, Diabetes + Obesity + Any of hypertension, reduced HDL or elevated triglyceride; + Any two, Diabetes + Obesity + Any two of hypertension, reduced HDL or elevated triglyceride; + Any three, Diabetes + Obesity + All three of hypertension, reduced HDL or elevated triglyceride; N, Total population with metabolic syndrome; n, Population with metabolic syndrome having microangiopathies